ArticleTherapeutic advances in gastroenterology2022

Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis.

Laura Besendorf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.